Aptevo Therapeutics Inc.
APVO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$24 | -$17 | $8 | -$28 |
| Dep. & Amort. | $0 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1 | $2 | $2 | $2 |
| Change in WC | -$1 | $3 | $2 | -$3 |
| Other Non-Cash | $0 | $0 | -$34 | $7 |
| Operating Cash Flow | -$24 | -$12 | -$21 | -$22 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$0 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | -$0 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$3 | -$12 | -$11 |
| Stock Issued | $10 | $6 | $7 | $10 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $6 | $3 | $3 | $26 |
| Financing Cash Flow | $16 | $6 | -$3 | $26 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$8 | -$6 | -$24 | $4 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $17 | $23 | $46 | $43 |
| End Cash | $9 | $17 | $23 | $46 |
| Free Cash Flow | -$24 | -$12 | -$21 | -$22 |